Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

NCT02872103 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Neutropenia

Interventions

DRUG: F-627
DRUG: Placebo

Sponsor

EVIVE Biotechnology